Therapeutic Botox – used for conditions that include muscle spasticity, migraines, overactive bladders, certain eye ...

The Relative Strength (RS) Rating for AbbVie ABBV moved into a higher percentile Thursday, as it got a lift from 64 to 71. Please watch the video at Investors.com - Do Your Stocks Meet This Key ...

The sharp profit fall was due to a provision of $37.75 million made by Glenmark to settle US antitrust and consumer ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

Key Points Collaboration and license revenue (GAAP) for Q2 2025 was $8.1 million but missed Q2 2025 GAAP revenue estimates by $0.11 million. Net loss (GAAP) widened to $15.8 million, with increased ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

AbbVie announced a significant expansion at its North Chicago facility, with plans to enhance U.S. production capacities for ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...